James S Economou

Title(s)Professor, Surgery
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Professor, MIMG

    Title(s)Professor, Molecular and Medical Pharmacology


    Collapse Overview 
    Collapse Overview
    Dr. James S. Economou holds the Louis D. Beaumont Chair in Surgery.

    Collapse Research 
    Collapse Research Activities and Funding
    PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN
    NIH R01CA129816Aug 13, 2007 - Jul 31, 2013
    Role: Principal Investigator
    Dendritic Cell-Based Genetic Immunotherapy for Melanoma
    NIH R01CA079976Jan 1, 1999 - Jan 31, 2008
    Role: Principal Investigator
    Genetic Immunotherapy for Hepatocellular Cancer
    NIH R01CA077623Apr 1, 1998 - Mar 31, 2006
    Role: Principal Investigator
    UCLA Clinical Scientist Training in Cancer Gene Medicine
    NIH K12CA076905Sep 30, 1997 - Jun 30, 2008
    Role: Principal Investigator
    UCLA CANCER GENE MEDICINE TRAINING PROGRAM
    NIH T32CA075956Sep 30, 1997 - Jun 30, 2007
    Role: Principal Investigator
    GENE THERAPY FOR CANCER
    NIH P01CA059326Sep 30, 1992 - Dec 31, 1998
    Role: Principal Investigator
    THERAPEUTIC REGULATION OF TNF IN IL-2 IMMUNOTHERAPY
    NIH R29CA050780Jul 1, 1989 - Jun 30, 1994
    Role: Principal Investigator
    REGULATION OF MACROPHAGE FUNCTION BY INTERLEUKIN-2
    NIH K08CA001360Jul 1, 1988 - Jun 30, 1991
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. One of the Most Important Phone Calls of My Career. Ann Surg. 2021 06 01; 273(6):1049-1050. Economou JS. PMID: 33979312.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Interleukin 32 expression in human melanoma. J Transl Med. 2019 04 05; 17(1):113. Paz H, Tsoi J, Kalbasi A, Grasso CS, McBride WH, Schaue D, Butterfield LH, Maurer DM, Ribas A, Graeber TG, Economou JS. PMID: 30953519; PMCID: PMC6449995.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    3. Immunotherapy Resistance by Inflammation-Induced Dedifferentiation. Cancer Discov. 2018 08; 8(8):935-943. Mehta A, Kim YJ, Robert L, Tsoi J, Comin-Anduix B, Berent-Maoz B, Cochran AJ, Economou JS, Tumeh PC, Puig-Saus C, Ribas A. PMID: 29899062; PMCID: PMC6076867.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    4. Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products. J Immunother. 2018 Jun; 41(5):248-259. Nowicki TS, Escuin-Ordinas H, Avramis E, Chmielowski B, Chodon T, Berent-Maoz B, Wang X, Kaplan-Lefko P, Yang L, Baltimore D, Economou JS, Ribas A, Comin-Anduix B. PMID: 29470191; PMCID: PMC5959255.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. Cancer Research in the 21st Century. Ann Surg. 2016 10; 264(4):555-65. Economou JS, Slamon DJ, Ribas A, Phelps ME. PMID: 27537535.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Engines of Discovery and Innovation. Ann Surg. 2016 09; 264(3):405-12. Economou JS. PMID: 27464615.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Gender bias in biomedical research. Surgery. 2014 Nov; 156(5):1061-5. Economou JS. PMID: 25262221.
      View in: PubMed   Mentions: 2     Fields:    
    8. Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. J Transl Med. 2014 Apr 05; 12:86. Butterfield LH, Economou JS, Gamblin TC, Geller DA. PMID: 24708667; PMCID: PMC4021640.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    9. Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway. J Immunol. 2014 Apr 15; 192(8):3981-9. Jazirehi AR, Kurdistani SK, Economou JS. PMID: 24639349; PMCID: PMC4136528.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    10. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clin Cancer Res. 2014 May 01; 20(9):2457-65. Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel TA, Ishiyama A, Czernin J, Radu CG, Wang X, Gjertson DW, Cochran AJ, Cornetta K, Wong DJ, Kaplan-Lefko P, Hamid O, Samlowski W, Cohen PA, Daniels GA, Mukherji B, Yang L, Zack JA, Kohn DB, Heath JR, Glaspy JA, Witte ON, Baltimore D, Economou JS, Ribas A. PMID: 24634374; PMCID: PMC4070853.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    11. Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor. Am J Clin Exp Immunol. 2014; 3(1):43-56. Jazirehi AR, Nazarian R, Torres-Collado AX, Economou JS. PMID: 24660121; PMCID: PMC3960761.
      View in: PubMed   Mentions: 16  
    12. Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy. Cancer Discov. 2013 Apr; 3(4):418-29. Ma C, Cheung AF, Chodon T, Koya RC, Wu Z, Ng C, Avramis E, Cochran AJ, Witte ON, Baltimore D, Chmielowski B, Economou JS, Comin-Anduix B, Ribas A, Heath JR. PMID: 23519018; PMCID: PMC3716460.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCellsCTClinical Trials
    13. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells. Mol Ther. 2013 May; 21(5):1044-54. Giannoni F, Hardee CL, Wherley J, Gschweng E, Senadheera S, Kaufman ML, Chan R, Bahner I, Gersuk V, Wang X, Gjertson D, Baltimore D, Witte ON, Economou JS, Ribas A, Kohn DB. PMID: 23380815; PMCID: PMC3666644.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    14. A society in transition: presidential remarks at the 65th Annual SSO Cancer Symposium. Ann Surg Oncol. 2012 Oct; 19(11):3293-7. Economou JS. PMID: 22805856; PMCID: PMC3442172.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy. J Transl Med. 2012 Jun 19; 10:127. Quatromoni JG, Wang Y, Vo DD, Morris LF, Jazirehi AR, McBride W, Chatila T, Koya RC, Economou JS. PMID: 22713761; PMCID: PMC3507675.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    16. Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLs. Mol Cancer Ther. 2012 Jun; 11(6):1332-41. Jazirehi AR, Economou JS. PMID: 22532603; PMCID: PMC3374071.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    17. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3. J Hematol Oncol. 2011 Nov 23; 4:48. Quatromoni JG, Morris LF, Donahue TR, Wang Y, McBride W, Chatila T, Economou JS. PMID: 22112546; PMCID: PMC3245424.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    18. Immunomodulation by imiquimod in patients with high-risk primary melanoma. J Invest Dermatol. 2012 Jan; 132(1):163-9. Narayan R, Nguyen H, Bentow JJ, Moy L, Lee DK, Greger S, Haskell J, Vanchinathan V, Chang PL, Tsui S, Konishi T, Comin-Anduix B, Dauphine C, Vargas HI, Economou JS, Ribas A, Bruhn KW, Craft N. PMID: 21850019; PMCID: PMC3229834.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    19. CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans. Clin Cancer Res. 2011 Jun 15; 17(12):4101-9. Huang RR, Jalil J, Economou JS, Chmielowski B, Koya RC, Mok S, Sazegar H, Seja E, Villanueva A, Gomez-Navarro J, Glaspy JA, Cochran AJ, Ribas A. PMID: 21558401; PMCID: PMC3117971.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCellsCTClinical Trials
    20. Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction. Cancer Res. 2011 Feb 15; 71(4):1406-17. Jazirehi AR, Baritaki S, Koya RC, Bonavida B, Economou JS. PMID: 21159666; PMCID: PMC4180868.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    21. Radiation enhances regulatory T cell representation. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):1128-35. Kachikwu EL, Iwamoto KS, Liao YP, DeMarco JJ, Agazaryan N, Economou JS, McBride WH, Schaue D. PMID: 21093169; PMCID: PMC3117954.
      View in: PubMed   Mentions: 193     Fields:    Translation:AnimalsCells
    22. MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro. Clin Immunol. 2010 Sep; 136(3):338-47. Ray S, Chhabra A, Chakraborty NG, Hegde U, Dorsky DI, Chodon T, von Euw E, Comin-Anduix B, Koya RC, Ribas A, Economou JS, Rosenberg SA, Mukherji B, UCLA-CALTECH-CHLA-USC-UCONN Consortium on Translational Program in Engineered Immunity. PMID: 20547105; PMCID: PMC2917536.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    23. Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma. Pigment Cell Melanoma Res. 2010 Apr; 23(2):288-9. Baltimore D, Witte ON, Yang L, Economou J, Ribas A. PMID: 20067554.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    24. Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma. Clin Dermatol. 2009 Nov-Dec; 27(6):603-13. Ray S, Chhabra A, Mehrotra S, Chakraborty NG, Ribas A, Economou J, Mukherji B. PMID: 19880048.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    25. Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824. Cancer Res. 2009 Nov 15; 69(22):8693-9. Vo DD, Prins RM, Begley JL, Donahue TR, Morris LF, Bruhn KW, de la Rocha P, Yang MY, Mok S, Garban HJ, Craft N, Economou JS, Marincola FM, Wang E, Ribas A. PMID: 19861533; PMCID: PMC2779578.
      View in: PubMed   Mentions: 87     Fields:    Translation:AnimalsCells
    26. Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res. 2009 Oct 01; 15(19):6267-76. Ribas A, Comin-Anduix B, Chmielowski B, Jalil J, de la Rocha P, McCannel TA, Ochoa MT, Seja E, Villanueva A, Oseguera DK, Straatsma BR, Cochran AJ, Glaspy JA, Hui L, Marincola FM, Wang E, Economou JS, Gomez-Navarro J. PMID: 19789309; PMCID: PMC2765061.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCellsCTClinical Trials
    27. Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade. Clin Cancer Res. 2009 Jan 01; 15(1):390-9. Ribas A, Comin-Anduix B, Economou JS, Donahue TR, de la Rocha P, Morris LF, Jalil J, Dissette VB, Shintaku IP, Glaspy JA, Gomez-Navarro J, Cochran AJ. PMID: 19118070.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    28. CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model. J Immunol. 2008 Jul 15; 181(2):1063-70. Chhabra A, Yang L, Wang P, Comin-Anduix B, Das R, Chakraborty NG, Ray S, Mehrotra S, Yang H, Hardee CL, Hollis R, Dorsky DI, Koya R, Kohn DB, Ribas A, Economou JS, Baltimore D, Mukherji B. PMID: 18606658; PMCID: PMC2715965.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    29. Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma. J Transl Med. 2008 May 01; 6:22. Comin-Anduix B, Lee Y, Jalil J, Algazi A, de la Rocha P, Camacho LH, Bozon VA, Bulanhagui CA, Seja E, Villanueva A, Straatsma BR, Gualberto A, Economou JS, Glaspy JA, Gomez-Navarro J, Ribas A. PMID: 18452610; PMCID: PMC2412852.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCellsCTClinical Trials
    30. Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma. J Immunother. 2008 Apr; 31(3):294-309. Butterfield LH, Comin-Anduix B, Vujanovic L, Lee Y, Dissette VB, Yang JQ, Vu HT, Seja E, Oseguera DK, Potter DM, Glaspy JA, Economou JS, Ribas A. PMID: 18317358; PMCID: PMC3651040.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCellsCTClinical Trials
    31. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer. Cancer Immunol Immunother. 2007 Dec; 56(12):1931-43. Butterfield LH, Ribas A, Potter DM, Economou JS. PMID: 17522860.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    32. Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma. Am J Ophthalmol. 2007 Jun; 143(6):958-969. Straatsma BR, Nusinowitz S, Young TA, Gordon LK, Chun MW, Rosen C, Seja E, Economou JS, Glaspy JA, Bozon V, Gomez-Navarro J, Ribas A. PMID: 17434437.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    33. NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain. J Immunol. 2006 Dec 15; 177(12):8448-55. Prins RM, Vo DD, Khan-Farooqi H, Yang MY, Soto H, Economou JS, Liau LM, Ribas A. PMID: 17142742.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    34. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. Clin Cancer Res. 2006 May 01; 12(9):2817-25. Butterfield LH, Ribas A, Dissette VB, Lee Y, Yang JQ, De la Rocha P, Duran SD, Hernandez J, Seja E, Potter DM, McBride WH, Finn R, Glaspy JA, Economou JS. PMID: 16675576.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCellsCTClinical Trials
    35. Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade). J Immunol. 2006 Apr 15; 176(8):4757-65. Schumacher LY, Vo DD, Garban HJ, Comin-Anduix B, Owens SK, Dissette VB, Glaspy JA, McBride WH, Bonavida B, Economou JS, Ribas A. PMID: 16585569.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCellsPHPublic Health
    36. Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays. Clin Cancer Res. 2006 Jan 01; 12(1):107-16. Comin-Anduix B, Gualberto A, Glaspy JA, Seja E, Ontiveros M, Reardon DL, Renteria R, Englahner B, Economou JS, Gomez-Navarro J, Ribas A. PMID: 16397031.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    37. Broad antitumor protection by dendritic cells administered to CD8alpha knock out mice. Cancer Immunol Immunother. 2006 Jun; 55(6):663-71. Ribas A, Vo DD, Weeks DL, Comin-Anduix B, Schumacher LY, Garban HJ, McLean C, Yang J, Dissette VB, Peraza P, Owens SK, McBride WH, Glaspy JA, Economou JS. PMID: 16133107.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    38. Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells. Cancer Gene Ther. 2005 Jun; 12(6):516-27. Wargo JA, Schumacher LY, Comin-Anduix B, Dissette VB, Glaspy JA, McBride WH, Butterfield LH, Economou JS, Ribas A. PMID: 15775996.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    39. Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells. Immunology. 2004 Dec; 113(4):472-81. Mehrotra S, Chhabra A, Chakraborty A, Chattopadhyay S, Slowik M, Stevens R, Zengou R, Mathias C, Butterfield LH, Dorsky DI, Economou JS, Mukherji B, Chakraborty NG. PMID: 15554925; PMCID: PMC1782594.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    40. Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy. J Immunother. 2004 Sep-Oct; 27(5):354-67. Ribas A, Glaspy JA, Lee Y, Dissette VB, Seja E, Vu HT, Tchekmedyian NS, Oseguera D, Comin-Anduix B, Wargo JA, Amarnani SN, McBride WH, Economou JS, Butterfield LH. PMID: 15314544.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCellsCTClinical Trials
    41. Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells. J Immunol. 2004 Aug 15; 173(4):2462-9. Liao YP, Wang CC, Butterfield LH, Economou JS, Ribas A, Meng WS, Iwamoto KS, McBride WH. PMID: 15294960.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    42. Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma. Control Clin Trials. 2004 Aug; 25(4):400-7. Gordon LK, Ribas A, Nusinowitz S, Butterfield LH, Glaspy JA, Economou JS, Straatsma BR. PMID: 15296814.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    43. Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses. J Immunother. 2004 May-Jun; 27(3):191-200. Schumacher L, Ribas A, Dissette VB, McBride WH, Mukherji B, Economou JS, Butterfield LH. PMID: 15076136.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    44. Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells. J Immunol. 2004 Apr 15; 172(8):4762-9. Ribas A, Wargo JA, Comin-Anduix B, Sanetti S, Schumacher LY, McLean C, Dissette VB, Glaspy JA, McBride WH, Butterfield LH, Economou JS. PMID: 15067052.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    45. T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5902-8. Butterfield LH, Ribas A, Meng WS, Dissette VB, Amarnani S, Vu HT, Seja E, Todd K, Glaspy JA, McBride WH, Economou JS. PMID: 14676113.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCellsCTClinical Trials
    46. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 2003 Oct; 14(10):1267-74. Lu DS, Raman SS, Limanond P, Aziz D, Economou J, Busuttil R, Sayre J. PMID: 14551273.
      View in: PubMed   Mentions: 148     Fields:    Translation:Humans
    47. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro. Cancer Res. 2003 Sep 01; 63(17):5607-14. Mehrotra S, Stevens R, Zengou R, Chakraborty NG, Butterfield LH, Economou JS, Dorsky DI, Mukherji B. PMID: 14500402.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    48. Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol. 2003 Jun 15; 21(12):2415-32. Ribas A, Butterfield LH, Glaspy JA, Economou JS. PMID: 12805342.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimals
    49. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Clin Cancer Res. 2003 Mar; 9(3):998-1008. Butterfield LH, Ribas A, Dissette VB, Amarnani SN, Vu HT, Oseguera D, Wang HJ, Elashoff RM, McBride WH, Mukherji B, Cochran AJ, Glaspy JA, Economou JS. PMID: 12631598.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCellsCTClinical Trials
    50. Determinant spreading and tumor responses after peptide-based cancer immunotherapy. Trends Immunol. 2003 Feb; 24(2):58-61. Ribas A, Timmerman JM, Butterfield LH, Economou JS. PMID: 12547500.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    51. Cancer immunotherapy using gene-modified dendritic cells. Curr Gene Ther. 2002 Feb; 2(1):57-78. Ribas A, Butterfield LH, Glaspy JA, Economou JS. PMID: 12108974.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    52. The status of gene therapy for surgical disease. Adv Surg. 2002; 36:223-57. Wargo JA, Economou JS. PMID: 12465553.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    James's Networks
    Concepts (260)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (32)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California